Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes
Status:
Withdrawn
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Work Package 1: Observational cohort pilot safety study Work Package 2: Randomised,
double-blind, placebo controlled pilot study Work Package 3: Observer-blind pilot RCT
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospitals of Derby and Burton NHS Foundation Trust
Collaborators:
BioPhage Theraputics Limited Nottingham University Hospitals NHS Trust Wellcome Trust